Related Experiment Video
Updated: Jun 24, 2025
04:29
Vagus Nerve Stimulation As an Adjunctive Neurostimulation Tool in Treatment-resistant Depression
Published on: January 7, 2019
28.6K
Treatment strategy for late-life depression
Hajime Baba1,2
1Department of Psychiatry, Faculty of Medicine, Juntendo Koshigaya Hospital Juntendo University Saitama Japan.
PCN Reports : Psychiatry and Clinical Neurosciences
|June 13, 2024
Summary
Late-life depression (LLD) management is complex due to diagnostic challenges and poorer treatment response in older adults. Tailored, patient-specific interventions, including psychotherapy and newer antidepressants, are crucial for effective LLD care.
Area of Science:
- Geriatrics
- Psychiatry
- Neuroscience
Background:
- Global population aging is increasing the incidence of late-life depression (LLD).
- LLD presents unique challenges in diagnosis and treatment compared to early-adult depression.
- Accurate diagnosis requires differentiating LLD from dementia, delirium, and other medical conditions.
Purpose of the Study:
- To review current management and treatment strategies for late-life depression.
- To highlight the complexities and specific considerations for treating depression in older adults.
- To outline evidence-based approaches for LLD based on treatment response levels.
Main Methods:
- Review of existing literature on late-life depression diagnosis and treatment.
- Analysis of treatment strategies, including psychotherapy, pharmacotherapy, and neuromodulation.
- Categorization of further-line treatment based on first-line response.
Main Results:
- LLD is characterized by poorer treatment response and higher recurrence rates than in younger populations.
- Psychosocial interventions, cognitive behavioral therapy, and problem-solving therapy show efficacy.
- Newer antidepressants are recommended, with careful monitoring for adverse events; neuromodulation is also beneficial.
Conclusions:
- Late-life depression is highly heterogeneous, necessitating individualized treatment plans.
- Treatment strategies must consider the patient's background, condition, and response to initial therapies.
- Personalized, multi-faceted approaches are essential for optimizing outcomes in LLD patients.
Related Concept Videos
01:23Antidepressant Drugs: MAOIs and Other Agents
220
Atypical antidepressants, including bupropion (Wellbutrin), mirtazapine (Remeron), nefazodone (Serzone), trazodone (Desyrel), and vilazodone (Viibryd), offer unique mechanisms of action. Bupropion weakly inhibits dopamine and norepinephrine reuptake, aiding depression treatment and smoking cessation, with a low risk of sexual dysfunction. Mirtazapine enhances serotonin and norepinephrine neurotransmission, leading to sedation, increased appetite, and weight gain. As a result, it helps treat...
220
01:24Treatment Strategies for Psychological Disorders
109
Treatment approaches for psychological disorders fall into three main categories: psychological, biological, and sociocultural. Each approach targets different aspects of mental health, requiring varying levels of education and training.
Psychological therapies focus on modifying emotions, thoughts, and behaviors through talking, interpreting, listening, rewarding, challenging, and modeling. Clinical psychologists, counselors, and social workers commonly practice psychotherapy. Clinical...
Psychological therapies focus on modifying emotions, thoughts, and behaviors through talking, interpreting, listening, rewarding, challenging, and modeling. Clinical psychologists, counselors, and social workers commonly practice psychotherapy. Clinical...
109
01:22Alzheimer's Disease: Treatment
179
Alzheimer's Disease (AD), a neurodegenerative disorder, is pathologically identified by amyloid plaques and neurofibrillary tangles composed of tau protein. AD pharmacotherapy aims to manage cognitive symptoms, delay disease progression, and treat behavioral symptoms. The treatment is primarily symptomatic and palliative, with no definitive disease-modifying therapy available. Cholinesterase inhibitors, including donepezil (Aricept), rivastigmine (Exelon), and galantamine (Razadyne), are...
179
01:28Drug Therapy
42
The advent of drug therapy has profoundly shaped modern mental health care, providing targeted treatments for a range of psychological disorders. Psychotherapeutic drugs, classified into antianxiety, antidepressant, and antipsychotic medications, address symptoms across anxiety disorders, mood disorders, and schizophrenia. While these medications have transformed patient outcomes, they require careful management due to their potential side effects and limitations.
Antianxiety Medications
Antianxiety Medications
42
01:30Electroconvulsive Therapy
31
Electroconvulsive therapy (ECT), or shock therapy, remains a critical biomedical intervention for severe, treatment-resistant depression. While its origins can be traced back to Hippocrates' observations that malaria-induced convulsions alleviated mental illness, modern ECT has evolved significantly from its earlier, more primitive applications. First introduced in 1938 by Ugo Cerletti and his colleagues, ECT involves inducing controlled seizures using electrical currents. In its early...
31
01:26Psychosis: Goals of Pharmacotherapy
122
Antipsychotic drugs are a crucial treatment method for acute and chronic psychoses, bipolar illness, and behavioral disorders. The selection of these drugs depends on several factors, including the state of the disease, clinical judgment, possible drug interactions, and the patient's sensitivity to adverse effects. In immediate scenarios, such as delirium and dementia, short-term treatment with low doses of high-potency typical or atypical agents can effectively manage symptom exacerbation.
122